食管早期腺癌与鳞状细胞癌的内镜管理:筛查、诊断与治疗
本文综述食管早期腺癌与鳞状细胞癌的内镜筛查、诊断与治疗进展。因早期症状不特异,诊断常被延迟,出现吞咽困难时多属晚期,5年生存率低于15%。内镜人群筛查不具成本效益,多种替代影像与细胞分析技术正在研究中;近10年 resection 与消融技术治疗异型增生(鳞状与巴雷特)及早期食管癌取得显著进展,并有随机对照试验证据支持。
要点
- 出现吞咽困难时多属晚期,5年生存率低于15%
- 内镜人群筛查不具成本效益,替代影像与细胞分析技术正在研究中
- 近10年切除与消融技术治疗食管异型增生及早期癌获随机对照试验证据支持
核心结论
- 食管早期腺癌与鳞状细胞癌可经内镜实现早期诊断与根治,但早期症状不特异致诊断延迟;综述的早期诊断与微创治疗技术有望降低疾病负担。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 出现吞咽困难时已属晚期,5年生存率低于15%。
- 内镜人群筛查不具成本效益,多种替代影像与细胞分析技术正在研究中。
- 理想筛查试验应廉价、耐受性好并适用于初级保健。
- 近10年切除与消融技术治疗异型增生(鳞状与巴雷特)及早期食管癌取得显著进展,并有随机对照试验证据支持。
关键数值与推荐
- 出现吞咽困难时已属晚期,5年生存率低于15%。
- 近10年切除与消融技术治疗异型增生(鳞状与巴雷特)及早期食管癌取得显著进展,并有随机对照试验证据支持。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Because the esophagus is easily accessible with endoscopy, early diagnosis and curative treatment of esophageal cancer is possible. However, diagnosis is often delayed because symptoms are not specific during early stages of tumor development. The onset of dysphagia is associated with advanced disease, which has a survival at 5 years lower than 15%. Population screening by endoscopy is not cost-effective, but a number of alternative imaging and cell analysis technologies are under investigation. The ideal screening test should be inexpensive, well tolerated, and applicable to primary care. Over the past 10 years, significant progress has been made in endoscopic diagnosis and treatment of dysplasia (squamous and Barrett's), and early esophageal cancer using resection and ablation technologies supported by evidence from randomized controlled trials. We review the state-of-the-art technologies for early diagnosis and minimally invasive treatment, which together could reduce the burden of disease.
引用
- di Pietro M, Canto MI, Fitzgerald RC, et al. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology. 2017. PMID: 28778650. doi:10.1053/j.gastro.2017.07.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。